Treatment with Hydroxychloroquine vs Hydroxychloroquine + Nitazoxanide in COVID-19 patients with risk factors for poor prognosis: A structured summary of a study protocol for a randomised controlled trial

OBJECTIVES: To determine the efficacy of Hydroxychloroquine vs. Hydroxychloroquine + Nitazoxanide in reducing the need for invasive mechanical ventilatory support for patients with COVID-19. Hydroxychloroquine is currently being used in multiple trials with varying doses in an attempt to treat COVID...

Descripción completa

Detalles Bibliográficos
Autores principales: Calderón, José Meneses, Zerón, Hugo Mendieta, Padmanabhan, Srivatsan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276957/
https://www.ncbi.nlm.nih.gov/pubmed/32513231
http://dx.doi.org/10.1186/s13063-020-04448-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276957/
https://www.ncbi.nlm.nih.gov/pubmed/32513231
http://dx.doi.org/10.1186/s13063-020-04448-2

Ejemplares similares